About this trial
This pilot study for stroke patients with chronic upper limb hemiplegia will examine the effects of non-invasive brain stimulation and neuromuscular electrical stimulation on hand motor control and corticospinal excitability. Specifically, this study will investigate the effects of timing and delivery of tDCS in conjunction with contralaterally controlled functional electrical stimulation.
Eligibility criteria
Qualifiers
Age ≥ 21
≥ 6 months since first clinical hemorrhagic or nonhemorrhagic stroke
Able to follow 3-stage commands and remember 2 of 3 items after 30 minutes
Full volitional elbow extension/flexion and hand opening/closing of unaffected limb
Disqualifiers
Co-existing neurological condition other than prior stroke involving the hemiparetic upper limb (e.g., peripheral nerve injury, Parkinson's disease, spinal cord injury, traumatic brain injury, multiple sclerosis).
Uncontrolled seizure disorder
Use of seizure lowering threshold medications at the discretion of the study physician (Dr. Rich Wilson)
Cardiac pacemaker or other implanted electronic device and/or stent
Trial design
Treatments tested in this trial
- transcranial direct current stimulation and electrical stimulator